Our previous investigations utilizing CD34 and α-smooth muscle actin (αSMA) immunohistochemistry revealed a reduction in CD34-positive cancer-associated fibroblasts (CAFs) and a rise in αSMA-positive CAFs within the tumor stroma [6]. This evidence concerns the gene CD34 and cancer.